Design and evaluation of controlled release mucoadhesive microspheres of amoxicillin for anti Helicobacter pylori therapy

Main Article Content

N Venkateswaramurthy
R Sambathkumar
P Perumal


The aim of this study was to develop controlled release mucoadhesive microspheres of amoxicillin trihydrate for the treatment of peptic ulcer disease caused by Helicobacter pylori (H. pylori). Microspheres were prepared by solvent evaporation technique using carbopol 974P, hydroxypropyl methyl cellulose K4M (HPMC K4M) and Eudragit RS 100. The prepared microspheres were subjected to evaluation for particle size, incorporation efficiency, in vitro mucoadhesion and in vitro drug release characteristics. Absence of drug-polymer interaction was confirmed using differential scanning calorimetry analysis and fourier transform infrared spectrophotometry. The prepared microspheres showed a strong mucoadhesive property. The polymer concentration influenced the in vitro drug release significantly in 0.1N HCl. The particle sizes of systems ranged
between 123±8.35 μm and 524±11.54 μm. Percent drug entrapment and release profiles of amoxicillin trihydrate in 0.1 N HCl were determined using high-performance liquid chromatography.The percentage drug entrapment and percentage yield of formulations were about 56.71±1.66% to 88.32±0.65% and 39.20±1.62% to 92.40±1.32%, respectively.The stability of the drugs was assessed in 0.1 N HCl. The results further substantiated that mucoadhesive microspheres improved the gastric stability of amoxicillin trihydrate (due to entrapment within the microsphere). From the above results, it was concluded
that the mucoadhesive microspheres of amoxicillin trihydrate has feasibility for eradicating H. pylori from the stomach more effectively because of the prolonged gastrointestinal residence time and controlled release of drug from the formulation.


Download data is not yet available.

Article Details

How to Cite
Venkateswaramurthy, N., Sambathkumar, R., & Perumal, P. (2014). Design and evaluation of controlled release mucoadhesive microspheres of amoxicillin for anti Helicobacter pylori therapy. Asian Journal of Pharmaceutics (AJP), 5(4).


Kleanthous H, lee CK, Monath TP. Vaccine development against infection

with Helicobacter pylori. Br Med Bull 1998;54:229-41.

Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of

patients with gastritis and peptic ulceration. Lancet 1984;1:1311-5.

Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N,

et al. Association between infection with Helicobacter pylori and risk

of gastric cancer: evidence from a prospective investigation. BMJ


Wotherspoon AC, Ortiz-hidalgo C, Falzon MR, Isaacso PG. Helicobacter

pylori associated gastritis a primary B-cell gastric lymphoma. Lancet


Murray CJ, Lopez AD. Alternative projections of mortality and

disability by cause 1990-2020: Global Burden of Disease Study. Lancet


Schistosomes, liver flukes and Helicobacter pylori. IARC working group

on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June

IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.

Risbud MV, Hardilar AA, Bhat SV, Bhonde KR. pH sensitive freeze-dried

chitosan-polyvinyl pyrolidone hydrogels as controlled release system

for antibiotic delivery. J Control Release 2000;68:23-30.

Kawabami E, Ogata SK, Portorreal AC, Magni AM, Pardo ML, Patrício FR.

Triple therapy with clarithromycin, amoxicillin and omeprazole

for Helicobacter pylori eradication in children and adolescents. Arq

Gastroenterol 2001;38:203-6.

Lin CK, Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, et al. One-week

quadruple therapy is an effective salvage regimen for Helicobacter

pylori infection in patients after failure of standard triple therapy. J Clin

Gastroenterol 2002;34:547-51.

Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum

amoxycillin concentrations after different oral application forms.

Antimicrob Agents Chemother 1993;37:1506-9.

Atherton JC, Cockayne A, Balsitis M, Kirk GE, Hawley CJ, Spiller RC.

Detection of the intragastric sites at which Helicobacter pylori evades

treatment with amoxicillin and cimetidine. Gut 1995;36:670-4.

Hirschl AM, Rotter ML. Amoxicillin for the treatment of Helicobacter

pylori infection. J Gastroenterol 1996;31 Suppl 9:44-7.

Conway BR. Drug Delivery Strategies for the treatment of Helicobacter

pylori Infections. Curr Pharm Des 2005;11:775-90.

Nagahara N, Akiyama Y, Nakao M, Tada M, Kitano M, Ogawa Y.

Mucoadhesive microspheres containing amoxicillin for clearance of

Helicobacter pylori. Antimicrob Agents Chemother 1998;42:2492-4.

Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 2003;255:13-32.

Lopedota A, Trapani A, Cutrignelli A, Chiarantini L, Pantucci E, Curci R,

et al. The use of Eudragit RS 100/cyclodextrin nanoparticles for the

transmucosal administration of glutathione. Eur J Pharm Biopharm


Singla AK, Chawla A, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review. Drug Dev IndPharm 2000;26:913-24.

Lubrizol. Formulating controlled release tablets and capsules with

carbopol polymers. Pharm Bull 2011;31:1-22.

Perez-Marcos B, Ford JL, Armstrong DJ, Elliott PN, Rostron C, Hogan JE.

Influence of pH on the release of propranolol hydrochloride from

matrices containing hydroxypropyl methylcellulose K4M and carbopol

J Pharm Sci 1996;85:330-4.

Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and

release properties of Carbopol gels in hydrophilic cosolvents. Int J

Pharm 2004;282:115-30.

Bravo SA, Lamas MC, Salomon CJ. Swellable Matrices for the Controlled- Release of Diclofenac Sodium: Formulation and in vitro Studies. PharmDev Technol 2004;9:75-83.

Erah PO, Goddard AF, Barrett DA, Shaw PN, Spiller RC. The stability

of amoxicillin, clarithromycin and metronidazole in gastric juice:

Relevance to the treatment of Helicobacter pylori infection. J Antimicrob

Chemother 1997;39:5-12.

Chun MK, Sah H, Choi HK. Preparation of mucoadhesive microspheres

containing antimicrobial agents for eradication of H. pylori. Int J Pharm


Bourne DW. Pharmacokinetics. In: Banker GS, Rhodes CT, editors. Modern Pharmaceutics. 4th ed. New York: Marcel Dekker Inc; 2002. p. 67-92.

Lehr CM, Bowstra JA, Tukker JJ, Junginger HE. Intestinal transit of

bioadhesive microspheres in an in situ loop in the rat. J Control Release


Higuchi, T. Mechanism of sustained-action medication. Theoretical

analysis of rate of release of solid drugs dispersed in solid matrices.

J Pharm Sci 1963;52:1145-9.

Korsemeyer RW, Gurny R, Docler E, Bur P, Peppas NA. Mechanism of solute release from porous hydrophilic polymer. Int J Pharm 1983;15:25-35.

Lee JH, Park TG, Choi HK. Development of oral drug delivery system

using floating microspheres. J Microencapsul 1999;16:715-29.

Dubey RR, Parikh RH. Two-stage optimization process for formulation

of chitosan microspheres. AAPS PharmSciTech 2004;5:E5.

Rafati H, Coombes AG, Adler J, Holland J, Davis SS. Protein-loaded

PLGA microparticles for oral administration: Formulation, structural

and release characteristics. J Control Release 1997;43:89-102.

Bodmeier R, McGinity JW. Solvent selection in the preparation of PLA

microspheres prepared by the solvent evaporation method. Int J Pharm


Bird AE. Amoxicillin. In: Harry GB, editor. Vol 23. Analytical Profiles of

Drug Substances and Excipient. San Diego: Academic Press; 1994. p. 4-51.

Lemoine D, Wauters F, Bouchend S, Preat V. Preparation and

characterization of alginate microspheres containing a model antigen.

J Pharm Sci 1998;176:9-19.

Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. Effect of formulation

variables on the floating properties of gastric floating drug delivery

system. Drug Dev Ind Pharm 2002;28:783-93.

Prudat-Christiaens C, Arnaud P, Allain P, Chaumeil JC. Aminophylline

bioadhesive tablets attempted by wet granulation. Int J Pharm


Soppimath KS, Kulkarni AR, Aminabhavi TM. Controlled release of

antihypertensive drug from the interpenetrating network poly (vinyl

alcohol)-guar gum hydrogel microspheres. J Biomater Sci Polym Ed


Rokhade AP, Agnihotri SA, Patil SA, Mallikarjuna NN, Kulkarni PV,

Aminabhavi TM. Semi-interpenetrating polymer network micro-spheres

of gelatin and sodium carboxy-methyl cellulose for controlled release

of ketorolac tromethamine. Carbohydr Polym 2006;65:243-52.

Blaha JM, Knevel AM, Kessler DP, Mincy JW, Hem SL. Kinetic analysis of

penicillin degradation in acidic media. J Pharm Sci 1976;65:1165-70.

Most read articles by the same author(s)